title: Long-term results with low glucose degradation product content in peritoneal dialysis fluids.
authors.affiliation: Departments of Nephrology and Physiology, University Hospital of Lund, Sweden. Bengt.Rippe@njur.lu.se
authors.forename: Bengt
authors.initials: B
authors.lastname: Rippe
authors.forename: Anders
authors.initials: A
authors.lastname: Wieslander
authors.forename: Barbara
authors.initials: B
authors.lastname: Musi
mesh_terms: D000368:Aged; D001672:Biocompatible Materials / Q000009:adverse effects; D015415:Biomarkers / Q000032:analysis; D018394:CA-125 Antigen / Q000032:analysis; D015314:Dialysis Solutions / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000009:adverse effects* / Q000378:metabolism*; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000379:methods*; D010537:Peritoneum / Q000187:drug effects* / Q000502:physiology; D011347:Procollagen / Q000032:analysis; D011446:Prospective Studies; D012016:Reference Values; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D001672:Biocompatible Materials; D015415:Biomarkers; D018394:CA-125 Antigen; D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D011347:Procollagen; D006820:Hyaluronic Acid; D005947:Glucose